Northland raised the firm’s price target on BioLife Solutions to $28 from $26 and keeps an Outperform rating on the shares after the company reported better-than-expected results and its third consecutive quarter of double-digit sequential growth.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BLFS: